Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26508862
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26508862
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Neuropsychiatr+Dis+Treat
2015 ; 11
(ä): 2667-73
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a
retrospective chart review
#MMPMID26508862
Nguyen L
; Marshalek PJ
; Weaver CB
; Cramer KJ
; Pollard SE
; Matsumoto RR
Neuropsychiatr Dis Treat
2015[]; 11
(ä): 2667-73
PMID26508862
show ga
OBJECTIVE: This study evaluated the effectiveness and safety of subanesthetic
doses of ketamine using an off-label, transmucosal administration route in
patients with treatment-resistant depression. METHODS: A retrospective chart
review was conducted to identify patients who met the inclusion criteria for
treatment-resistant major depressive disorder. Seventeen such patients who
received subanesthetic doses of ketamine were included. Patient demographics,
efficacy (drug refill, clinician notes), side effects, and concurrent medications
were assessed. RESULTS: Benefit from low-dose transmucosal ketamine was noted in
76% of subjects (average age 48 years, 88% female), with a dose duration lasting
7-14 days. No notable side effects were noted. The most common classes of
concurrent medications to which ketamine was added were serotonin-norepinephrine
reuptake inhibitors (59%), stimulants (47%), folate replacement (47%), and
benzodiazepines (47%). CONCLUSION: Our results provide preliminary evidence of
the effectiveness and safety of low-dose transmucosal ketamine in
treatment-resistant patients. A controlled, prospective pilot study is warranted
to validate these findings.